Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Country / region: United Kingdom Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20063
20072
20081
20102
20121
20133
20145
20151
20171
20181
20191
20201
20211
20222
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affymax4
Bayer4
AstraZeneca3
Boehringer Ingelheim3
Novartis Pharmaceuticals3
GlaxoSmithKline2
Pfizer2
AMAG Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Astellas Pharma Europe B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic35
Anemia12
Kidney Failure, Chronic7
Diabetic Nephropathies3
Hypertension3
Albuminuria2
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Kidney Diseases2
Anemia, Iron-Deficiency1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.